The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus) has affected people from different parts of the World and has been a major cause for significant morbidity and mortality to date. Coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, can present with various clinical features and while pulmonary manifestation is the most common, hepatic abnormalities can be encountered in up to 50% of infected individuals. 1,2 The spectrum is variable and can range from asymptomatic abnormalities in hepatic biochemical tests to severe liver injury with some reports of acute-on-chronic liver failure in patients with underlying cirrhosis. [3][4][5] Hepatic dysfunction has been associated with poor outcome and which has been noted to be more frequent in critically ill